From Biotech Daily:
Today, Imugene executive chair Paul Hopper told Biotech Daily that “the situation had changed” and the company would source pembrolizumab elsewhere.Mr Hopper said the trial was “still full speed ahead” and the costs of the drug were not material.
- Forums
- ASX - By Stock
- Ann: Pause in Trading
From Biotech Daily:Today, Imugene executive chair Paul Hopper...
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.0¢ |
Change
0.001(1.69%) |
Mkt cap ! $439.1M |
Open | High | Low | Value | Volume |
6.0¢ | 6.1¢ | 5.8¢ | $1.072M | 18.07M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 85851 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 335299 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25799 | 0.060 |
3 | 500000 | 0.059 |
12 | 972875 | 0.058 |
15 | 1426878 | 0.057 |
17 | 1741276 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 17344 | 1 |
0.062 | 1392807 | 3 |
0.063 | 1810181 | 8 |
0.064 | 310883 | 7 |
0.065 | 939557 | 9 |
Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
Last
6.1¢ |
  |
Change
0.001 ( 2.37 %) |
|||
Open | High | Low | Volume | ||
5.9¢ | 6.1¢ | 5.8¢ | 7197252 | ||
Last updated 15.59pm 07/06/2024 ? |
Featured News
IMU (ASX) Chart |